Cambridge Investment Research Advisors
ABMD

Cambridge Investment Research Advisors’s Abiomed Inc ABMD Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-960
Closed -$236K – 3249
2022
Q3 		$236K Sell
960
-18
-2% -$4.86K ﹤0.01% 2573
2022
Q2 		$242K Buy
978
+68
+7% +$18.4K ﹤0.01% 2563
2022
Q1 		$301K Buy
910
+66
+8% +$20.3K ﹤0.01% 2558
2021
Q4 		$303K Sell
844
-28
-3% -$9.46K ﹤0.01% 2518
2021
Q3 		$284K Sell
872
-16
-2% -$5.42K ﹤0.01% 2510
2021
Q2 		$277K Sell
888
-335
-27% -$103K ﹤0.01% 2538
2021
Q1 		$390K Sell
1,223
-92
-7% -$29.4K ﹤0.01% 2085
2020
Q4 		$426K Sell
1,315
-13,637
-91% -$3.77M ﹤0.01% 1882
2020
Q3 		$4.14M Buy
14,952
+13,403
+865% +$3.86M 0.03% 526
2020
Q2 		$374K Buy
1,549
+22
+1% +$4.42K ﹤0.01% 1713
2020
Q1 		$222K Sell
1,527
-566
-27% -$94K ﹤0.01% 1868
2019
Q4 		$357K Buy
2,093
+129
+7% +$23.9K ﹤0.01% 1805
2019
Q3 		$349K Buy
1,964
+208
+12% +$45K ﹤0.01% 1725
2019
Q2 		$457K Buy
1,756
+110
+7% +$29.2K ﹤0.01% 1485
2019
Q1 		$470K Buy
1,646
+192
+13% +$63.8K ﹤0.01% 1520
2018
Q4 		$473K Sell
1,454
-8,327
-85% -$2.89M 0.01% 1357
2018
Q3 		$4.4M Buy
9,781
+642
+7% +$253K 0.04% 411
2018
Q2 		$3.74M Buy
9,139
+146
+2% +$52.9K 0.04% 421
2018
Q1 		$2.62M Buy
8,993
+206
+2% +$52.2K 0.03% 539
2017
Q4 		$1.65M Sell
8,787
-289
-3% -$54K 0.02% 654
2017
Q3 		$1.53M Buy
+9,076
New +$1.37M 0.02% 635

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cambridge Investment Research Advisors's ABMD Position: Q4 2022 in Review

Cambridge Investment Research Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 960 shares — an estimated $236K sold.

Cambridge Investment Research Advisors first reported a position in ABMD in Q3 2017 and held it in 21 quarters. The position peaked at $4.4M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Cambridge Investment Research Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 960 Abiomed Inc shares in Q4 2022, an estimated $236K.
  • Cambridge Investment Research Advisors first reported a position in Abiomed Inc in Q3 2017 and held it in 21 quarters.
  • Cambridge Investment Research Advisors's Abiomed Inc position peaked at $4.4M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.